Primary Care Poc Diagnostics Market
Primary Care POC Diagnostics Market Forecasts to 2030 - Global Analysis By Product (Urinalysis, Ambulatory Chemistry, Infectious Diseases Testing Kits and Other Products), Technology, Sample Type, Distribution Channel, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $16.7 BN |
|
Projected Year Value (2030) |
US $29.5 BN |
|
CAGR (2023 - 2030) |
8.5% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Primary Care POC Diagnostics Market is accounted for $16.7 billion in 2023 and is expected to reach $29.5 billion by 2030 growing at a CAGR of 8.5% during the forecast period. Primary Care Point-of-Care (POC) Diagnostics are diagnostic tools and tests used in primary care settings that enable medical professionals to get test results right away in close proximity to the patient. These tests are carried out at the point of patient care, or in close proximity to it, providing quick and easy access to diagnostic data for prompt clinical decision-making. During patient consultations, these tests enable healthcare practitioners to make prompt clinical judgments since they yield data quickly often in a matter of minutes. Maintaining high-quality testing and dependable findings in primary care settings requires POC diagnostics to ensure accuracy, dependability, and compliance with regulatory criteria.
According to the World Health Organization (WHO), approximately 354 million people globally are hepatitis B or C positive, and diagnosis and treatment are unavailable. The WHO aims to control and reduce new infections by 90% and deaths by 65% by 2030.
Market Dynamics:
Driver:
Demand for point-of-care solutions in healthcare settings
The availability of rapid testing at the point of patient care is encouraged by the need for point-of-care solutions. This allows for quick clinical choices and timely treatments during patient consultations in primary care by providing quick access to diagnostic information. This diagnostics speeds up test results considerably by removing the requirement to ship samples to centralized laboratories. This quick access to information facilitates more effective workflows in primary care settings and speeds up patient care, especially for urgent situations which further enhance the growth of the market.
Restraint:
Price pressure as a result of reduced reimbursement and financial limitations
Lower reimbursements or reimbursement for point-of-care (POC) diagnostic tests may result in higher expenses for patients or healthcare institutions. This may result in a decrease in the cost or availability of certain tests, particularly for smaller primary care clinics or underprivileged communities. Additionally, financial restrictions may force healthcare institutions to choose less expensive, lower-quality point-of-care (POC) diagnostic tests, which might compromise test range, accuracy, or reliability with stunt in the growth of the market.
Opportunity:
Demand for immediate diagnostic results
Immediate outcomes' main objective is to speed up clinical decision-making in primary care settings. Point-of-care (POC) diagnostics allow medical professionals to quickly and intelligently decide how best to treat patients at a single visit. These diagnostics drastically shorten the time it takes to get test results by doing away with the requirement for centralized laboratories. Thus, quick information availability guarantees quick interventions and speeds up the diagnostic procedure creating wide range of opportunities for the market.
Threat:
Lack of accuracy and reliability
Results from primary care point-of-care diagnostic tests that are inaccurate or untrustworthy may result in misdiagnoses, ineffective therapies, or a delay in essential actions. This might have a detrimental effect on health outcomes and jeopardize patient safety. When primary care POC diagnostic tests with a track record of errors are used by healthcare practitioners or institutions, patients may become dissatisfied or lose faith in them. Patient trust in their medical care and satisfaction may be impacted by this.
Covid-19 Impact
Demand for rapid point-of-care (POC) diagnostics surged in response to the need for quick and easily accessible SARS-CoV-2 testing. In primary care settings, procedures such molecular POC testing and lateral flow assays (LFAs) have become indispensable for rapid COVID-19 identification. Moreover, telehealth services and remote testing choices proliferated in an attempt to reduce exposure and preserve social isolation. Thus a few POC tests were modified for use in telemedicine so that patients may take tests at home under the supervision of a remote provider.
The ambulatory chemistry segment is expected to be the largest during the forecast period
The ambulatory chemistry segment is estimated to have a lucrative growth, as the term ""ambulatory chemistry"" describes the practice of doing biochemical analyses or chemistry tests outside of a conventional laboratory environment, usually at point-of-care (POC) or ambulatory care settings. The principal objective is to expedite and accurately collect basic biochemistry test findings to facilitate prompt clinical decision-making during patient consultations in ambulatory or primary care settings. When biochemical tests are performed in ambulatory settings, patients can visit less centralized facilities for routine testing, which can save time and facilitate diagnosis.
The lateral flow assays (LFAs) segment is expected to have the highest CAGR during the forecast period
The lateral flow assays (LFAs) segment is anticipated to witness the highest CAGR growth during the forecast period, because these tests are easy to use, quick to complete, and reasonably priced. They are intended to find out whether a certain analyze is present in biological samples like blood, urine, saliva, or other body fluids. These tests are appropriate for use in primary care or point-of-care (POC) settings where prompt findings are essential for making timely clinical choices thus encourage the growth of the market.
Region with largest share:
North America is projected to hold the largest market share during the forecast period because so many primary care facilities in the United States use POC equipment and the significant portion of this regional market has also been linked to the existence of significant firms in the nation providing goods and services for primary settings. Healthcare providers are being urged by the Centers for Medicare & Medicaid Services to start patient engagement initiatives. The market is being driven by this as well as the availability of financing for healthcare R&D by academic institutions boost the growth of the market in this region.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the availability of several cutting-edge and creative POC diagnostic solutions, the Asia-Pacific market is comparatively more developed than the rest of the globe. Another important growth driver is the increasing demand for these solutions in primary home healthcare and supported healthcare settings. This is explained by the fact that more businesses are taking use of the unrealized potential in the area. Furthermore, it is anticipated that the Asia Pacific market would develop as a result of rising public awareness of the need of early illness diagnosis to increase patient survival rates.
Key players in the market
Some of the key players profiled in the Primary Care POC Diagnostics Market include BD Biosciences, Roche Diagnostics, Abbott Laboratories, bioMerieux, Instrumentation Laboratory, Quidel Corporation, Danaher Corporation, Siemens Healthcare, Agilent Technologies, Decode Genetics, Axis-Shield, Becton Dickinson, Nova Biomedical, Trividia Health, Inc., OraSure Technologies, Inc. and Abaxis
Key Developments:
In November 2023, BD launched a new, advanced ultrasound system designed to help improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines and other vascular access devices.
In November 2023, BD a leading global medical technology company, and Bio Farma, a state-owned life science company in Indonesia, signed a memorandum of understanding (MOU) for a joint effort to combat tuberculosis (TB)
In September 2023, bbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.
Products Covered:
• Urinalysis
• Ambulatory Chemistry
• Infectious Diseases Testing Kits
• Lipid Testing
• Glucose Monitoring Devices
• Hematology Testing Devices
• Blood Gas/Electrolytes
• Hb1Ac Testing
• Autoimmune Disease
• Coagulation Monitoring Devices
• Cardiac Markers
• Thyroid Stimulating Hormone Devices
• Drug Abuse Testing
• Pregnancy & Fertility Testing Products
• Other Products
Technologies Covered:
• Immunoassays
• Lateral Flow Assays (LFAs)
• Molecular Diagnostics
• Clinical Chemistry
• Electrochemical & Biosensor Technologies
• Other Technologies
Sample Types Covered:
• Urine
• Blood
• Nasal & Oropharyngeal Swabs
• Other Sample Types
Distribution Channels Covered:
• Pharmacies
• Retail clinics
• E-comm. Platforms
• Other Distribution Channels
End Users Covered:
• Home Care & Self Testing
• Hospitals
• Critical Care Centers & Urgent care centers
• Ambulatory Care Facilities
• Clinical Laboratories
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Primary Care POC Diagnostics Market, By Product
5.1 Introduction
5.2 Urinalysis
5.3 Ambulatory Chemistry
5.4 Infectious Diseases Testing Kits
5.5 Lipid Testing
5.6 Glucose Monitoring Devices
5.7 Hematology Testing Devices
5.8 Blood Gas/Electrolytes
5.9 Hb1Ac Testing
5.10 Autoimmune Disease
5.11 Coagulation Monitoring Devices
5.12 Cardiac Markers
5.13 Thyroid Stimulating Hormone Devices
5.14 Drug Abuse Testing
5.15 Pregnancy & Fertility Testing Products
5.16 Other Products
6 Global Primary Care POC Diagnostics Market, By Technology
6.1 Introduction
6.2 Immunoassays
6.3 Lateral Flow Assays (LFAs)
6.4 Molecular Diagnostics
6.5 Clinical Chemistry
6.6 Electrochemical & Biosensor Technologies
6.7 Other Technologies
7 Global Primary Care POC Diagnostics Market, By Sample Type
7.1 Introduction
7.2 Urine
7.3 Blood
7.4 Nasal & Oropharyngeal Swabs
7.5 Other Sample Types
8 Global Primary Care POC Diagnostics Market, By Distribution Channel
8.1 Introduction
8.2 Pharmacies
8.3 Retail clinics
8.4 E-comm. Platforms
8.5 Other Distribution Channels
9 Global Primary Care POC Diagnostics Market, By End User
9.1 Introduction
9.2 Home Care & Self Testing
9.3 Hospitals
9.4 Critical Care Centers & Urgent care centers
9.5 Ambulatory Care Facilities
9.6 Clinical Laboratories
10 Global Primary Care POC Diagnostics Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 BD Biosciences
12.2 Roche Diagnostics
12.3 Abbott Laboratories
12.4 bioMerieux
12.5 Instrumentation Laboratory
12.6 Quidel Corporation
12.7 Danaher Corporation
12.8 Siemens Healthcare
12.9 Agilent Technologies
12.10 Decode Genetics
12.11 Axis-Shield
12.12 Becton Dickinson
12.13 Nova Biomedical
12.14 Trividia Health, Inc.
12.15 OraSure Technologies, Inc.
12.16 Abaxis
List of Tables
1 Global Primary Care POC Diagnostics Market Outlook, By Region (2021-2030) ($MN)
2 Global Primary Care POC Diagnostics Market Outlook, By Product (2021-2030) ($MN)
3 Global Primary Care POC Diagnostics Market Outlook, By Urinalysis (2021-2030) ($MN)
4 Global Primary Care POC Diagnostics Market Outlook, By Ambulatory Chemistry (2021-2030) ($MN)
5 Global Primary Care POC Diagnostics Market Outlook, By Infectious Diseases Testing Kits (2021-2030) ($MN)
6 Global Primary Care POC Diagnostics Market Outlook, By Lipid Testing (2021-2030) ($MN)
7 Global Primary Care POC Diagnostics Market Outlook, By Glucose Monitoring Devices (2021-2030) ($MN)
8 Global Primary Care POC Diagnostics Market Outlook, By Hematology Testing Devices (2021-2030) ($MN)
9 Global Primary Care POC Diagnostics Market Outlook, By Blood Gas/Electrolytes (2021-2030) ($MN)
10 Global Primary Care POC Diagnostics Market Outlook, By Hb1Ac Testing (2021-2030) ($MN)
11 Global Primary Care POC Diagnostics Market Outlook, By Autoimmune Disease (2021-2030) ($MN)
12 Global Primary Care POC Diagnostics Market Outlook, By Coagulation Monitoring Devices (2021-2030) ($MN)
13 Global Primary Care POC Diagnostics Market Outlook, By Cardiac Markers (2021-2030) ($MN)
14 Global Primary Care POC Diagnostics Market Outlook, By Thyroid Stimulating Hormone Devices (2021-2030) ($MN)
15 Global Primary Care POC Diagnostics Market Outlook, By Drug Abuse Testing (2021-2030) ($MN)
16 Global Primary Care POC Diagnostics Market Outlook, By Pregnancy & Fertility Testing Products (2021-2030) ($MN)
17 Global Primary Care POC Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
18 Global Primary Care POC Diagnostics Market Outlook, By Technology (2021-2030) ($MN)
19 Global Primary Care POC Diagnostics Market Outlook, By Immunoassays (2021-2030) ($MN)
20 Global Primary Care POC Diagnostics Market Outlook, By Lateral Flow Assays (LFAs) (2021-2030) ($MN)
21 Global Primary Care POC Diagnostics Market Outlook, By Molecular Diagnostics (2021-2030) ($MN)
22 Global Primary Care POC Diagnostics Market Outlook, By Clinical Chemistry (2021-2030) ($MN)
23 Global Primary Care POC Diagnostics Market Outlook, By Electrochemical & Biosensor Technologies (2021-2030) ($MN)
24 Global Primary Care POC Diagnostics Market Outlook, By Other Technologies (2021-2030) ($MN)
25 Global Primary Care POC Diagnostics Market Outlook, By Sample Type (2021-2030) ($MN)
26 Global Primary Care POC Diagnostics Market Outlook, By Urine (2021-2030) ($MN)
27 Global Primary Care POC Diagnostics Market Outlook, By Blood (2021-2030) ($MN)
28 Global Primary Care POC Diagnostics Market Outlook, By Nasal & Oropharyngeal Swabs (2021-2030) ($MN)
29 Global Primary Care POC Diagnostics Market Outlook, By Other Sample Types (2021-2030) ($MN)
30 Global Primary Care POC Diagnostics Market Outlook, By Distribution Channel (2021-2030) ($MN)
31 Global Primary Care POC Diagnostics Market Outlook, By Pharmacies (2021-2030) ($MN)
32 Global Primary Care POC Diagnostics Market Outlook, By Retail clinics (2021-2030) ($MN)
33 Global Primary Care POC Diagnostics Market Outlook, By E-comm. Platforms (2021-2030) ($MN)
34 Global Primary Care POC Diagnostics Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
35 Global Primary Care POC Diagnostics Market Outlook, By End User (2021-2030) ($MN)
36 Global Primary Care POC Diagnostics Market Outlook, By Home Care & Self Testing (2021-2030) ($MN)
37 Global Primary Care POC Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
38 Global Primary Care POC Diagnostics Market Outlook, By Critical Care Centers & Urgent care centers (2021-2030) ($MN)
39 Global Primary Care POC Diagnostics Market Outlook, By Ambulatory Care Facilities (2021-2030) ($MN)
40 Global Primary Care POC Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
